Tumor delivery of macromolecular drugs based on the EPR effect

被引：1605

作者：

Torchilin, Vladimir ^{[1
]}

机构：

[1] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2011年 / 63卷 / 03期

关键词：

Tumors; Drug delivery; EPR effect; Protein drugs; Peptide drugs; Polymeric drugs; Pharmaceutical nanocarriers; Tumor targeting; Intracellular drug delivery; PEGYLATED-LIPOSOMAL DOXORUBICIN; LONG-CIRCULATING LIPOSOMES; PHASE-II TRIAL; IN-VIVO; ENHANCED PERMEABILITY; TARGETED DELIVERY; VASCULAR-PERMEABILITY; POLYMERIC MICELLES; SOLID TUMORS; CANCER;

D O I：

10.1016/j.addr.2010.03.011

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Enhanced permeability and retention (EPR) effect is the physiology-based principal mechanism of tumor accumulation of large molecules and small particles. This specific issue of Advanced Drug Delivery Reviews is summing up multiple data on the EPR effect-based drug design and clinical outcome. In this commentary, the role of the EPR effect in the intratumoral delivery of protein and peptide drugs, macromolecular drugs and drug-loaded long-circulating pharmaceutical nanocarriers is briefly discussed together with some additional opportunities for drug delivery arising from the initial EPR effect-mediated accumulation of drug-containing macromolecular systems in tumors. (C) 2010 Elsevier B.V. All rights reserved.

引用

页码：131 / 135

页数：5

共 50 条

[1] Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, Hiroshi
BIOCONJUGATE CHEMISTRY, 2010, 21 (05) : 797 - 802
[2] Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS
Maeda, H
Sawa, T
Konno, T
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) : 47 - 61
[3] Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H.
Bharate, G. Y.
Daruwalla, J.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) : 409 - 419
[4] Effect of increasing vascular hydraulic conductivity on delivery of macromolecular drugs to tumor cells
El, Kareh, A.W.
Secomb, T.W.
International Journal of Radiation Oncology, Biology, Physics, 1995, 32 (05):
[5] Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls
Nakamura, Hideaki
Jun, Fang
Maeda, Hiroshi
EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (01) : 53 - 64
[6] EFFECT OF INCREASING VASCULAR HYDRAULIC CONDUCTIVITY ON DELIVERY OF MACROMOLECULAR DRUGS TO TUMOR-CELLS
ELKAREH, AW
SECOMB, TW
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (05): : 1419 - 1423
[7] Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H
Wu, J
Sawa, T
Matsumura, Y
Hori, K
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) : 271 - 284
[8] Oral delivery of macromolecular drugs
Tang, P
Wang, NF
Dinh, SM
POLYMERIC DRUG DELIVERY I: PARTICULATE DRUG CARRIERS, 2006, 923 : 68 - 83
[9] The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Maeda, Hiroshi
Nakamura, Hideaki
Fang, Jun
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) : 71 - 79
[10] Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting
Maeda, Hiroshi
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2012, 88 (03): : 53 - 71

← 1 2 3 4 5 →